Compare Quest Diagnostics Inc (DGX) vs Peloton Interactive Inc (PTON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Peloton Interactive Inc — how do they compare? Quest Diagnostics Inc trades at $230.97 (market cap $25.48B), while Peloton Interactive Inc trades at $5.12 (market cap $2.16B). The key difference: Quest Diagnostics Inc is far larger — about 11.8× Peloton Interactive Inc's market cap, and Quest Diagnostics Inc pays a 1.49% dividend while Peloton Interactive Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Peloton Interactive Inc for 37 Days on average.
| DGX | PTON | |
|---|---|---|
Market Cap | $25.48B | $2.16B |
Volume | 941,866 | 11,369,487 |
Sector | Health | Consumer Cyclical |
52-Week High | $247.45 | $7.86 |
52-Week Low | $173.49 | $3.71 |
Typical Hold Time | 56 Days | 37 Days |
Enterprise Value | $31.23B | $2.66B |
Dividend Yield | 1.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.97, up 1.75% today, with a technical bias leaning bearish despite recent earnings beats. Revenue grew to $11.04B in 2025, with net income reaching $992M, though profit margins have moderated. Analyst consensus is a $250 price target with a mixed buy/hold sentiment. Recent news highlights growth in consumer testing and partnerships, alongside concerns over potential Medicare reimbursement cuts.
The outlook balances solid fundamentals and growth initiatives against regulatory risks. Upside potential exists from continued operational execution and new ventures like the Apple Health app integration, but investors face headwinds from reimbursement uncertainty and a high debt load. The stock's valuation appears reasonable relative to peers, supporting a cautious but opportunistic view.
Peloton (PTON) trades at $4.92, up 1.44% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported its first full-year net profit in fiscal 2026, with revenue of $2.49B in 2025 and improving margins. Recent news highlights the launch of new, more affordable treadmills and AI-powered features as part of its turnaround strategy.
The outlook is mixed; analyst consensus is a Buy with a $8.00 price target, signaling potential upside, but risks include high debt, negative equity, and subscriber declines. Execution of the product refresh and cost management will be critical for sustained profitability and stock performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Peloton Interactive Inc
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →
